Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (241-250 of 500) with videos related to

Pageof 50
Sort By:
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.
Cancer|May 16, 2020
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor StudyMukta Arora, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2019
Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor StudyRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infectionGhislaine Gallez-Hawkins, Lia Thao, Simon F Lacey, et al.
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Transplantation and Cellular Therapy|May 29, 2026
The Influence of Race/Ethnicity and Social Vulnerability on Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant in Older (≥60 Years) AdultsRusha Bhandari, Haoyue Shan, Jorge Ramos-Perez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2018
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with <sup>89</sup>Zr-OxineMichael R Weist, Renate Starr, Brenda Aguilar, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Open Forum Infectious Diseases|August 13, 2024
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold InfectionJustine Abella Ross, Brian Lee, Huiyan Ma, et al.
Pageof 50

Showing results (241-250 of 500) with videos related to

Sort By:
Pageof 50
Human Gene Therapy|August 10, 2007
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domainsJinjuan Wang, Michael Jensen, Yukang Lin, et al.
Cancer|May 16, 2020
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor StudyMukta Arora, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2019
Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor StudyRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infectionGhislaine Gallez-Hawkins, Lia Thao, Simon F Lacey, et al.
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Transplantation and Cellular Therapy|May 29, 2026
The Influence of Race/Ethnicity and Social Vulnerability on Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant in Older (≥60 Years) AdultsRusha Bhandari, Haoyue Shan, Jorge Ramos-Perez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 14, 2020
Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell TransplantationMonzr M Al Malki, Joo Y Song, Dongyun Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2018
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with <sup>89</sup>Zr-OxineMichael R Weist, Renate Starr, Brenda Aguilar, et al.
Cancer|August 22, 2019
Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 studyElias J Jabbour, Nicola Gökbuget, Hagop M Kantarjian, et al.
Open Forum Infectious Diseases|August 13, 2024
Impact of Antifungal Prophylaxis Continuation or Discontinuation After Allogeneic Hematopoietic Cell Transplant on the Incidence of Invasive Mold InfectionJustine Abella Ross, Brian Lee, Huiyan Ma, et al.
Pageof 50